Literature DB >> 3128162

Recombinant interferons alpha and gamma: comparative antiviral activity and synergistic interaction in encephalomyocarditis virus infection of mice.

I S Sim1, R L Cerruti.   

Abstract

The antiviral properties of 2 recombinant DNA-produced interferons, a human hybrid interferon alpha that is active in mice and a murine interferon gamma, were examined in the treatment of mice infected with encephalomyocarditis virus. A single dose of interferon alpha induced a protective state in mice more rapidly than did interferon gamma, but the activity of the latter was more long lasting. When interferon and virus were administered 6 h apart, either intraperitoneally or intravenously, interferons alpha and gamma were equally effective. However, this was not the case when the routes of treatment and infection were different. Interferon alpha showed somewhat reduced activity when the route of administration (intravenous) was different from the route of virus challenge (intraperitoneal) while interferon gamma showed very little activity when tested in this manner. When interferons alpha and gamma were administered in combination to mice, a marked synergistic antiviral effect was observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3128162     DOI: 10.1016/0166-3542(87)90075-1

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  2 in total

1.  Broad-spectrum in vivo antiviral activity of 7-thia-8-oxoguanosine, a novel immunopotentiating agent.

Authors:  D F Smee; H A Alaghamandan; H B Cottam; B S Sharma; W B Jolley; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

2.  Immunoenhancing properties and antiviral activity of 7-deazaguanosine in mice.

Authors:  D F Smee; H A Alaghamandan; J Gilbert; R A Burger; A Jin; B S Sharma; K Ramasamy; G R Revankar; H B Cottam; W B Jolley
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.